Loading clinical trials...
Loading clinical trials...
Immunoadsorption in Addition to the Established Therapy in Patients With Systemic Sclerosis
The purpose of this study is to evaluate source data for the survival and the investigation of the preliminary efficacy of immunoadsorption in patients with severe systemic sclerosis.
Age
18 - 85 years
Sex
ALL
Healthy Volunteers
No
Universitätsklinikum Dresden
Dresden, Germany
Start Date
April 1, 2011
Primary Completion Date
July 1, 2012
Completion Date
August 1, 2012
Last Updated
August 19, 2015
1
ACTUAL participants
TheraSorb Ig
DEVICE
Lead Sponsor
GWT-TUD GmbH
Collaborators
NCT07090226
NCT07326033
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT03508375